chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After my vaccine, I noticed some neuromuscular differences in my body.  When I first wake up in the morning, and go to stretch in bed, it's like there's a "hitch" in my body between my intention to stretch and my body's response - kind of a like a little jerk when the muscles "catch".  Also, when I first wake up and put weight on my feet for the first time, there is a moment when my legs won't hold me, and then tense and pause before supporting my weight.  This had never happened before, and I noticed it after the vaccine.  Also, I have noticed a tremor in my hands.  I did not mention this to anyone initially, for two reasons:  first I was avoiding the truth that something had changed in my body - call it denial - it scared me.  Second, I am a busy professional, and after the initial moments of the day when I notice the reactions, I tend to forget about it and go on with the responsibilities of my life.  When I mentioned it to my health care provider, she asked if I had signed up with I got my vaccine to log any side effects (who knows?  I don't remember being offered that option) and noted that VAERS was only for life threatening side effects.  I don't know if these side effects would eventually become life threatening, but I did want to record them somewhere, as I am concerned that they could eventually affect my quality of life.
ANGINA, UNSPECIFIED 4/28/2023 SOLITARY PULMONARY NODULE ANGINA, UNSPECIFIED 4/28/2023 CHEST PAIN COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)  ANGINA, UNSPECIFIED 4/28/2023 ANGINA, UNSPECIFIED
Itchy rash around the injection site; Itchy rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy rash around the injection site) and VACCINATION SITE RASH (Itchy rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment.
low fever; bad headache; was extremely exhausted that she slept for three days; was extremely exhausted that she slept for three days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 05Feb2021 (Lot number: EL9265) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; FISH OIL; MULTIVITAMINS & MINERALS PLUS LUTEIN. The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "low fever"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "bad headache"; FATIGUE (non-serious), SOMNOLENCE (non-serious) all with onset 2021, outcome "unknown" and all described as "was extremely exhausted that she slept for three days".  Additional information: The patient reported that after the first dose of the Pfizer Covid-19 vaccine, she had complaints of a low fever, very bad headache, and was extremely exhausted that she slept for three days.    No follow-up attempts are possible. No further information is expected.
Information has been received from a 75 year old female patient. The patient's concomitant therapies included metformin, lisinopril and glipizide. The patient's pertinent medical history included diabetes. The patient had none drug reactions/allergies. In 2003 (reported as 15 years ago) the patient was vaccinated with ZOSTAVAX (1 injection, route was reported as injection, strength, frequency, lot# and expiration date were unknown) for prophylaxis (reported as shingles prevention). In 2015 (reported as 3 years ago) the patient was diagnosed with shingles. Treatment was given for the event. No lab diagnostics or studies were performed for the event. The patient had sought medical attention. The outcome of the event was recovered. The causality assessment was not provided by the reporter.
18 month old male patient received expired daptacel vaccine, no AE; Initial information was received on 03-Mar-2020 regarding an unsolicited valid non-serious case from a consumer.  This case involves an 18 month old male patient who received a 0.5 mL dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5367AA and expiry date: 30-Jan-2020) via an intramuscular route in the right thigh for prophylactic vaccination on 02-Mar-2020 for prophylactic vaccination.  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A) for Immunisation.  It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Vaccine used past its 30 day expiry date; patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2022 at 3:38 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Feb-2022 at 3:38 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine used past its 30 day expiry date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported dose number was reported as Booster It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the MFG expiry date of 04-Apr-2022. No treatments were reported
Bells Palsy (Left facial droop) and headaches Treated with 7 days steroids and 10 days antivirals  No change after 14 days
patient was expecting to get the updated pfizer booster (bivalent) and ended up receiving the monovalent
Immunization given at 8am. School contacted parent. Patient was complaining of dizziness, had difficulty walking, fever of 101.  Slept at home until this AM.  12/22 Seen by provider.  Temp 103 given Tylenol at clinic.  Wheezing (history of asthma) weakness and difficulty walking.  Treatment-Tylenol, Rule out viral infection.  Local injection site sore/red.
first 3 days sore arm around injection site; mild headache; woke up 4am with nerve-like pain in left arm in middle of night starting at injection site in shoulder and going down arm to first and second fingers, with slightly less intense pain radiating out to entire arm (and to pinky finger).; This is a spontaneous report from a contactable consumer reported herself. A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 11May2021 01:00 (Batch/Lot Number: EW0177) as a Single Dose for covid-19 immunization. The patient past Medical history included long mumps. The patient's concomitant medications were not reported. The patient previously took Penicillin B. On 28May2021 at 04:00, The patient experienced first 3 days sore arm around injection site, mild headache. No other side effects until 16 and woke up 4am with nerve-like pain in left arm in middle of night starting at injection site in shoulder and going down arm to first and second fingers, with slightly less intense pain radiating out to entire arm (and to pinky finger). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, prior to vaccination and the patient was not tested for COVID-19. The outcome for all the events recovered on Unspecified date 2021.  No follow-up attempts are needed. No further information is expected.
pt recv vax 18JUL97 & 4AUG97 pt returned to office low grade temp 100, lethargy;pt scattered lesion few dx w/chickenpox;
Less than 5 mins after receiving the vaccine the pt reported feeling dizzy, moments later he lost consciousness for approximately 10 sec, he was bradycardic but didn't lose a pulse. He awoke became diaphoretic and soon after vomited. he was lying down with knees and legs in the air. BP 90/50. HR 57. He reported being "back to normal" 15 mins after.
I started out on Monday with the headache and progressed to a fever and not feeling great. It did progressingly get worse. Wednesday, I noticed that I lost my sense of taste and smell and I noted that there was an antiviral for people my age. I also took an at-home test and that came back positive. I went to the urgent care and they noted that I definitely had COVID-19 and didn?t retest me. They prescribed the Paxlovid and that helped me tremendously. I felt better within a few days and just hung around. Once I took the antiviral, that really seemed to help. I just had no sense of taste or smell for a month afterwards. I self-quarantined for 5 days and, then on day 8 I was still testing positive. Then a couple more days later it came back negative. Not having taste for a month was strange When I drank water, it would taste metallic and the taste would just be awful. Smell came back within about 2 weeks. But since then, i' ve been doing just fine.
early menopause:  My Menstrual period stopped after first dose of Moderna vaccine. I had the first dose of Moderna Covid vaccine last 24Apri2021, lot 017C21A. I had the shot at Pharmacy. I thought it was just temporary. I had my second dose was on 22May2021, lot 024C21A. I was only 47yo. I never had problem with my cycle until after I had the Moderna COVID vaccine. This affected negatively my sexual life and eventually my self-esteem.
5 month 9/1/06 pt mother took baby to ER state left leg turned red, diagnosis was severe allergic local reaction.
Pain in arm, neck, shoulder. Headache, sore throat, cough, diarrhea
Information has been received from a consumer who refers to his 25 year old wife (see MARRS # 1410USA008581) and his 5 week old infant. On 14-OCT-2014, the consumer reported that his wife received M-M-R II vaccination (conflicting information, also reported by the physician as PROQUAD (Merck), (lot#, expiry date, dose and route not reported), while she was lactating and nursing their infant. On the evening of 14-OCT-2014, the consumer and his wife were notified by the health care professional's staff, that his wife should discontinue breast-feeding their infant immediately. The consumer stated that after his wife received PROQUAD (Merck), on 14-OCT-2014, she breast-fed their infant "4 or 5 times" during that day, on 14-OCT-2014, before being instructed to discontinue breast-feeding. The consumer reported that he purchased a breast-pump and formula so that the mother and infant could make the transition to formula-feeding. The consumer stated that his infant "has been sleeping more and has been spitting-up more." The consumer was concerned about his infant's well-being. Additional information has been requested.
I NOTICED MY LYMPH NODE WAS SWOLLEN AND TENDER IN THE ARMPIT AREA ON SUNDAY MAY 23 2021
Within 2 hours site was extremely sore and tender to touch, started experiencing numbness and tingling from shoulder to finger tips, today experiencing pain lower neck, shoulder and back of neck,  warm and painful, numbness and tingling continues.
The day after receiving a flu vaccine and a pneumonia vaccine pt c/o temp 99.6, chills shaking, feeling cold. The left arm, which received the pneumonia vaccine, was extremely sore. She vomited once .A day later, she felt back to normal  after rest and fluids.
she took Tylenol to prevent fever; one fever from other things, nothing worry about now; This is a spontaneous report from a contactable consumer.  A female patient of unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 09Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  On an unspecified date, after the vaccination, the patient took Tylenol to prevent fever and one fever from other things. The events assessed as non-serious. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (PRD/SRD (11May2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
Within 4 hours dibiltating headache, muscles aches. Not relieved by TYLENOL. Went to bed for 24 hours. Second dose given 10/18/2018 at 4:40PM .... three hours later had pounding headache and muscle aches. Went to bed for 48 hours. No relief from TYLENOL take one hour prior or additional doses during the next 48 hours.
rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included COLECALCIFEROL (VITAMIN D 3) and NAPROXEN (MOTRIN [NAPROXEN]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs). At the time of the report, RASH (rashes over the cheeks/ rashes over both ears/ rashes over the chest/ rashes over the stomach/ rashes over the abdomen/ rashes over the upper thighs) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient was reported to receive treatment for the symptoms developed. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-055550 (Patient Link).
Severe allergic reaction after 2 weeks of 1st shot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (Severe allergic reaction after 2 weeks of 1st shot) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Severe allergic reaction after 2 weeks of 1st shot). At the time of the report, HYPERSENSITIVITY (Severe allergic reaction after 2 weeks of 1st shot) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Email
Pt recvd a Hep B vax series (3 injects) & it is not known if pt seroconverted p/receiving the initial series; however, in NOV91 pt was tested for HBSAB & it was determined that pt had no antibodies; pt will be revaxed;
8 days after INFLUENZA vaccine @ deltoid, developed (R) hand numbness, tingling, (R) shoulder pain, (R) ear pain, (R) eye pain, MRI normal Head, (R) eye corneal abrasion, funduscopic exam normal, Prescribed PREDNISONE 100mg taper ACYCLOVIR - pt is pregnant and responding to meds - likely early Bell's palsy.
After receiving H1N1 vaccine 1pm, pt had fever up to 104.5, chills.
Received report that client was admitted to the hospital on Feb 27th with persistent tachycardia.  Called client on March 11 to inquire. Client shared that she has felt weak since having COVID-19 in September 2020 and was hospitalized for 3 months.  She shared she has felt weak since having COVID-19. She shared that on the morning after receiving the vaccine she was getting out of her bed, which is on the floor, and she hit her head.  She shared that her daughter was concerned and took her to the emergency department (ED). While there in the ED her  blood work ?wasn?t right? and they thought she might have a small blood clot in her lung and she was admitted. While in the hospital she received eliquis which she had a reaction to.  She shared she was in the hospital for 1 day. Recommended she see her PCP for these health concerns as well as before receiving the 2nd dose of a COVID-19/Moderna vaccine.
Bright red skin rash halfway around the arm; swelling; pain; suspect swollen lymph nodes on inside of arm. Blisters formed on day 2. One became as large as a lima bean. As rash subsided, blisters went down. Skin discoloration resulted and persists to today. Pain and swelling gone as of 11/06/2021.
CHILLS, FEVERISH, CHEST PAIN, MUSCLE ACHES, SWELLING IN LEFT SIDE OF NECK, NECK PAIN
Severe high blood pressure  General weakness, long asking fatigue, pain, cognitive function and memory problems, brain fog, inability to exercise or function normally. Physical and mental well-being continue to decline with time.
Headache, NauseaVomiting, COLD SWEATS/NIGHT SWEATES Narrative:
Information has been received from a physician concerning a 12 month old pt who on an unspecified date was vaccinated with a dose of MMR II/Varicella vaccine. Subsequently a couple of days after vaccination the pt broke out in an allergic type reaction with reddish bumps all over the body. The physician reported it was like a measles type rash. At the time of the report the pt was recovering. There was no product quality complaint involved. Additional information has been requested.
Itching hands, feet, to arms, legs, scalp, inside ears, Benadryl 25 mg Qhs
Patient was inadvertently given an expired dose of Kinrix. No side effects, patient's parent contacted and advised per CDC guidelines that patient should receive another dose of Kinrix.
This spontaneous case reported by a consumer, describes the occurrence of muscle rigidity (tightness) in a 32-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# unknown) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; .5 mL. On an unknown date, received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; .5 mL. On an unknown date, patient experienced muscle rigidity (tightness). At the time of the report, muscle rigidity (tightness) outcome: unknown. The patient did not received any treatment. Concomitant medications details and treatment information not reported. Action taken with mRNA-1273 (Moderna COVID-19 vaccine) in response to the event: not applicable.
Medium-size bruise noted slight down and away from injection site. Patient reports no pain or swelling with the bruise. Patient reports having taken Aleve the night before and morning of injection day.
blood pressure has been up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure has been up) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included blood clot (Back in 2016, she had a blood clot and was put on Eliquis for 4 months). Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL (ZESTRIL) for Hypertension, ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced HYPERTENSION (blood pressure has been up). At the time of the report, HYPERTENSION (blood pressure has been up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were reported.
Vaccine was administered 3 days after vial expiration date.  Parent informed by provider. Provider has chosen not to revaccinate.  Parent agreed.
HEADACHE; SORE ARM; This spontaneous report received from a consumer concerned a 33 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included developmentally challenged.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018,expiry: 25/MAY/2021) dose was not reported, administered in right arm on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced sore arm. On 24-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 23-MAR-2021, and had not recovered from headache. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Rash on chest, low grade fever, severe headache, diarrhea, shivering, metallic taste, loss of taste, loss of appetite. Still being affected after three days.
Chills, body ache, horrible runny nose, cough, sore throat, chest ache. Prescribe PAXLOVID.